KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Short-Term Debt repayments (2017 - 2021)

Historic Short-Term Debt repayments for Abbott Laboratories (ABT) over the last 2 years, with Q4 2021 value amounting to $195.0 million.

  • Abbott Laboratories' Short-Term Debt repayments changed N/A to $195.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $195.0 million, marking a year-over-year change of. This contributed to the annual value of $195.0 million for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q4 2021, Abbott Laboratories' Short-Term Debt repayments is $195.0 million.
  • In the past 5 years, Abbott Laboratories' Short-Term Debt repayments ranged from a high of $479.0 million in Q1 2017 and a low of $195.0 million during Q4 2021